Robin A Nadar
Overview
Explore the profile of Robin A Nadar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nadar R, Asokan N, Degli Esposti L, Curci A, Barbanente A, Schlatt L, et al.
Nanoscale
. 2020 Jun;
12(25):13582-13594.
PMID: 32555916
Hydroxyapatite (HA) nanoparticles are commonly used as building blocks in the design of bone-substituting biomaterials. Recently, these nanoparticles have been considered for the treatment of metastasis disease, since their pH-dependent...
2.
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity
Nadar R, Farbod K, der Schilden K, Schlatt L, Crone B, Asokan N, et al.
Sci Rep
. 2020 Apr;
10(1):5889.
PMID: 32246003
Platinum-based chemotherapeutics exhibit excellent antitumor properties. However, these drugs cause severe side effects including toxicity, drug resistance, and lack of tumor selectivity. Tumor-targeted drug delivery has demonstrated great potential to...
3.
Barbanente A, Nadar R, Degli Esposti L, Palazzo B, Iafisco M, van den Beucken J, et al.
J Mater Chem B
. 2020 Mar;
8(14):2792-2804.
PMID: 32159578
Chemotherapeutic treatment of patients with bone tumors or bone metastases often leads to severe side effects such as high drug toxicity, lack of tumor specificity and induced drug resistance. A...
4.
Pant K, Sedlacek O, Nadar R, Hruby M, Stephan H
Adv Healthc Mater
. 2017 Feb;
6(6).
PMID: 28218487
Owing to their tunable blood circulation time and suitable plasma stability, polymer-based nanomaterials hold a great potential for designing and utilising multifunctional nanocarriers for efficient imaging and effective treatment of...
5.
Nadar R, Margiotta N, Iafisco M, van den Beucken J, Boerman O, Leeuwenburgh S
Adv Healthc Mater
. 2017 Feb;
6(8).
PMID: 28207199
Bone metastases result from the invasion of primary tumors to bone. Current treatment modalities include local treatments such as surgery and radiotherapy, while systemic treatments include chemotherapy and (palliative) treatment...